ACCENTIA BIOPHARMACEUTICALS INC

Inactive Instrument

Accentia Biopharmaceuticals Inc Stock

Stocks

Biotechnology & Medical Research

Press Releases: Accentia Biopharmaceuticals Inc

12/09/12	Accentia Biopharmaceuticals Inc : Biovest Names Lymphoma Key Opinion Leader from MD Anderson Cancer Center to Scientific Advisory Board	PU
13/07/12	Accentia Biopharmaceuticals Inc : Biovest’s Eligibility to Seek EU Marketing Approval for its BiovaxID Cancer Vaccine as Orphan Drug Confirmed by EMA	PU
30/05/12	Accentia Biopharmaceuticals Inc : Biovest Names Dr. Eduardo Sotomayor, Chair of Dept of Malignant Hematology at Moffitt Cancer Center, to its Scientific Advisory Board	PU
19/05/12	Accentia Biopharmaceuticals Inc : Biovest Announces BiovaxID® ASCO Abstract Available On-line; NCI to Present Cancer Vaccine Data from Mantle Cell Lymphoma Study	PU
16/05/12	Accentia Biopharmaceuticals Inc : Biovest Retains Ferghana Partners to Evaluate Strategic Transactions	PU

More press releases

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ACCENTIA BIOPHARMACEUTICALS INC	-.--%	-.--%	-	-	0
	WUXI APPTEC CO., LTD.	+4.16%	+3.04%	+49.37%	+94.17%	74.46B
	ARGENX SE	-0.61%	+0.81%	+27.25%	+82.72%	60.14B
	LONZA GROUP AG	-2.54%	-1.65%	+4.86%	+31.72%	48.15B
	IQVIA HOLDINGS INC.	-3.02%	-5.20%	+27.94%	+32.51%	44.25B
	REVOLUTION MEDICINES, INC.	+0.31%	+3.02%	+348.95%	+643.82%	43.99B
	BEONE MEDICINES AG	-1.96%	-0.33%	+7.04%	+99.46%	41.61B
	CELLTRION, INC.	+3.32%	+3.49%	+10.10%	+51.23%	29.97B
	WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+8.00%	+36.77%	+22.78%	29.31B
	INSMED INCORPORATED	-4.86%	-10.66%	-26.27%	+330.06%	24.93B
	Average	-0.04%	-0.08%	+54.00%	+154.28%	44.09B
	Weighted average by Cap.	+0.17%	+0.11%	+58.36%	+145.78%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!